OverviewChartNewsTraderScreen

JP Morgan Put 45 BMY 17.05.2024/  DE000JK2QJR3  /

EUWAX
2024-04-26  10:51:02 AM Chg.+0.078 Bid9:59:50 PM Ask9:59:50 PM Underlying Strike price Expiration date Option type
0.099EUR +371.43% 0.092
Bid Size: 25,000		 0.100
Ask Size: 25,000		 Bristol Myers Squibb... 45.00 USD 2024-05-17 Put
GlobeNewswire 04-25 International Myeloma Foundation Holds 15th Annual Gala at the Edison Ballroom in New York City on A...
GlobeNewswire 04-25 Purple Biotech's Randomized Phase 2 CM24 Pancreatic Cancer Study Selected as Late-Breaking Abstract ...
GlobeNewswire 04-25 Nucleome Therapeutics appoints Dr John Davis as Non-Executive Director of the Board and establishes ...
GlobeNewswire 04-22 ArriVent Appoints Kristine Peterson to its Board of Directors
GlobeNewswire 04-08 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Bristol-Myers Sq...
GlobeNewswire 04-08 Dr. Chi Li Joins Curevo Vaccine as Chief Regulatory Officer
GlobeNewswire 04-08 TScan Therapeutics Appoints Seasoned Hematology and Oncology Expert Chrystal U. Louis, M.D., M.P.H.,...
GlobeNewswire 04-08 CytomX Therapeutics Announces First Patient Dosed with CX-2051, a Conditionally Activated EpCAM-Dire...
GlobeNewswire 04-05 Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies D...
GlobeNewswire 04-03 Standard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for Use of the...
GlobeNewswire 04-03 CytomX Therapeutics Announces Nomination of Second Clinical Candidate in Broad PROBODY® T-Cell Engag...
GlobeNewswire 04-02 MaxCyte Signs Strategic Platform License with Be Biopharma to Support the Development of Engineered ...
GlobeNewswire 04-02 Indegene Hosts Inaugural Strategic Advisory Board Meeting Chaired By Renowned Global Biopharma Leade...
GlobeNewswire 04-02 Avalo Therapeutics Appoints Biotech Leaders to Board of Directors
GlobeNewswire 04-01 Gain Therapeutics Strengthens Management Team and Appoints Jonas Hannestad, M.D., Ph.D. as Chief Med...
GlobeNewswire 04-01 Autolus Therapeutics Announces Changes to its Board of Directors
GlobeNewswire 03-31 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Bristol-Myers Sq...
GlobeNewswire 03-29 Molecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business Update
GlobeNewswire 03-28 Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Year 2023 Financial ...
GlobeNewswire 03-26 Healis Therapeutics announces collaboration with Massachusetts General Hospital (MGH) and affiliates...
GlobeNewswire 03-26 Attovia Enhances Clinical and Development Expertise with Appointment of Chief Medical Officer and Cl...
GlobeNewswire 03-23 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Bristol-Myers Sq...
GlobeNewswire 03-21 CytomX Therapeutics Appoints Dr. Zhen Su to Board of Directors
GlobeNewswire 03-21 Immatics Announces Full Year 2023 Financial Results and Corporate Update
GlobeNewswire 03-21 Angelini Ventures invests into extended €75.8 million ($82 million) Series C financing round for Nou...